Cardiovascular risk assessment and prevention strategies must be tailored specifically for women by incorporating female-specific risk factors such as pregnancy complications and autoimmune disorders.
Highlights the historical gender disparity in cardiovascular care and the recent improvements in cardiovascular mortality for women in the U.S. due to better prevention and management.
first paragraph of articleFor many years, cardiovascular disease was considered predominantly a disease of men, despite the fact that more U.S. women than men died annually from cardiovascular illness.1 Because of this misperception of their cardiovascular risk, for many years women were underdiagnosed and undertreated, with consequent increases in cardiovascular morbidity, mortality, and disability. With recent appreciation of this historical gender disparity, clinical and epidemiological research studies have identified cardiovascular features specific to women, resulting in an improved spectrum of care. Although since 1984 more U.S. women than men died annually from cardiovascular disease, beginning in the year 2000 there was a sharp decline in cardiovascular mortality for women, indeed, more precipitous than that for men. Half of this favorable effect is considered due to improved preventive strategies and the remainder to improved management of recognized cardiovascular disease. In 2013, for the first time, more U.S. men than women died of cardiovascular disease and we are delighted to be in second place.
Nanette K. Wenger (Mon,) conducted a review in Cardiovascular disease. Cardiovascular risk assessment and prevention strategies must be tailored specifically for women by incorporating female-specific risk factors such as pregnancy complications and autoimmune disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: